Quotes 5-day view Delayed Xetra
05/20/2022
05/23/2022
05/24/2022
05/25/2022
05/26/2022
Date
63.74(c)
64.47(c)
63.29(c)
63.78(c)
65.9(c)
Last
2 625 237
2 202 703
2 582 622
1 738 849
3 149 253
Volume
+0.54%
+1.15%
-1.83%
+0.77%
+3.32%
Change
Estimated financial data (e) EUR USD
Sales 2022
47 605 M
51 067 M
51 067 M
Net income 2022
4 996 M
5 360 M
5 360 M
Net Debt 2022
33 100 M
35 507 M
35 507 M
P/E ratio 2022
13,0x
Yield 2022
3,35%
Sales 2023
48 921 M
52 479 M
52 479 M
Net income 2023
5 667 M
6 079 M
6 079 M
Net Debt 2023
30 650 M
32 879 M
32 879 M
P/E ratio 2023
11,5x
Yield 2023
3,70%
Capitalization
64 742 M
69 450 M
69 450 M
EV / Sales 2022
2,06x
EV / Sales 2023
1,95x
Nbr of Employees
100 753
Free-Float
100,0%
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (45.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (41.6%) : intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc. ;
- OTC...
News in other languages on BAYER AG
Analyst Recommendations on BAYER AG
GE unit boosts medical dye output as China COVID lockdown cuts supplies
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BAYER AG
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
26
Last Close Price
65,90 €
Average target price
77,65 €
Spread / Average Target
17,8%
Please enable JavaScript in your browser's settings to use dynamic charts.